/
/
/

Gland Pharma Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)2,915.00
Volume (₹)20.62 L
High (₹)2,940.90
Upper Circuit3,489.40
Low (₹)2,851.10
Lower Circuit2,326.40
Prev Close2,907.90
52W High (₹)3,039.80
Price2,924.90
52W Low (₹)1,573.60

Share Market Cap & Key Ratios Overview

M.Cap (₹)47920.30 Cr
Div. Yield (%)0.69
PE Ratio42.45
Debt to Equity0.02
Price to Book2.71
Book Value625.91
EPS (TTM)68.43
Face Value1.00
ROE (%)10.56

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
GLANDNSE
LTP
1W Low
1W High
Market cap (₹)
1904.8-15.2 (-0.79%)
1902
1984.80
4,56,833Cr
9190-49 (-0.53%)
9087
9467
2,45,426Cr
4901-149 (-2.95%)
4886.50
5066
1,87,320Cr
1133.9-57.1 (-4.79%)
1125.10
1187
1,13,217Cr
1390.6-32.9 (-2.31%)
1376.70
1426.10
1,12,212Cr
1853.5-85 (-4.38%)
1811.70
1949
1,01,155Cr
2126.3-45.2 (-2.08%)
2118.10
2192
97,626Cr
2351.8-31.1 (-1.31%)
2341.20
2419.20
96,859Cr
1164.1-13.9 (-1.18%)
1154.40
1179.90
96,406Cr
1654.3+9 (0.55%)
1622.60
1717
93,614Cr
2924.9+36.9 (1.28%)
2803
2948
47,920Cr

Key Highlights of Gland Pharma Ltd Balance Sheet

Gland Pharma Ltd balance sheet discloses shareholders' funds of ₹16.48Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹16.48Cr, and the reserves and surplus of the company is ₹10748Cr.

The company has its non-current liabilities with total liabilities of ₹11607.2Cr as of 2026-03-31.

The current liabilities are ₹633.02Cr as of 2026-03-31. At the same time, current assets are ₹6422.22Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹3292.55Cr and tangible assets of ₹1688.43Cr, provided in the Gland Pharma Ltd financial statements.